Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02153307 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The "MARE" Study

Study acronym: MARE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Jul 2024 to Jul 2026v12
  2. Study completion date: Jul 2023 to Jul 2024v11
  3. 2 versions Re-verified since Sep 20, 2021, no change to tracked fieldsv9-v10
  4. Study completion date: Jul 2020 to Jul 2023v8
  5. Primary completion date: May 2019 to May 2020v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Jul 2018 to May 2019
    • Study completion date: Jul 2019 to Jul 2020
    v6
  2. Study completion date: Jul 2018 to Jul 2019v5
  3. Primary completion date: Jul 2016 to Jul 2018v4
  4. Phase: Phase 4 to Not applicablev3
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transcatheter aortic valve implantation (TAVI) and to evaluate the usefulness of the Reveal LINQ® insertable Cardiac Monitor (ICM) (Medtronic, Inc., Minneapolis, USA) for the detection of significant arrhythmias in patients with NOP-LBBB following TAVI.
Trial Details
NCT Number NCT02153307
Lead Sponsor Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Conditions
(from sponsor)		 Aortic Valve Disease, Conduction Disturbances
Related terms Aortic Valve Disease
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov